This inventor holds 1 USPTO granted patent and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mitsubishi Pharma Corporation, Novartis Ag. Active years: 2012.
Company Filing History:
1 out of 73 
1 out of 3,975 
Years Active: 2012
Title: The Innovations of Tomoyuki Oomura
Introduction
Tomoyuki Oomura is a notable inventor based in Oita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions. His work has been recognized for its potential impact on oral administration of medications.
Latest Patents
Oomura holds a patent for a solid pharmaceutical composition comprising a SIP receptor agonist and a sugar alcohol. This innovative formulation is designed to enhance the effectiveness of oral medications, making it a valuable addition to pharmaceutical science. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Throughout his career, Oomura has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Mitsubishi Pharma Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.
Collaborations
Oomura has collaborated with esteemed colleagues such as Madhusudhan Pudipeddi and Colleen Ruegger. These partnerships have fostered an environment of innovation and have led to advancements in pharmaceutical compositions.
Conclusion
Tomoyuki Oomura's contributions to the pharmaceutical industry highlight his innovative spirit and dedication to improving medication delivery. His work continues to influence the field, paving the way for future advancements in oral pharmaceutical compositions.